Nexomics Biosciences Competitors and Similar CompaniesClear all

Nexomics Biosciences's competitors and similar companies include Kolon Life Science, CytoMed Therapeutics, Reglagene and Amgen.
Nexomics Biosciences
Nexomics Biosciences
Nexomics Biosciences is a contract research organization offering gene-to‑structure services to the biopharmaceutical community.
Kolon Life Science
Kolon Life Science
Kolon Life Science is a cell and gene therapy company.
CytoMed Therapeutics
CytoMed Therapeutics
CytoMed Therapeutics is a company that focuses on translating its technologies into gamma delta (γδ) T cell- and natural killer (NK) cell-based immunotherapeutics for the treatment of cancers.
Reglagene
Reglagene
Reglagene is a company that discovers and develops noninvasive therapeutic solutions that regain control of genes exploited by cancer to keep patients responsive to treatment.
Amgen
Amgen
Amgen (formerly known as Applied Molecular Genetics) is a biotechnology company that discovers, develops, manufactures, and delivers human therapeutics.
Founding Date
Founding Date
2007
Founding Date
2000
Founding Date
2018
Founding Date
2016
Founding Date
1980
Type
Type
Private
Type
Public
Type
Private
Type
Private
Type
Public
Tags
Locations
Locations
Rocky Hill, US HQ
Mansfield, US
Locations
HQ
Locations
Singapore, SG HQ
Masai, MY
Locations
Tucson, US HQ
Locations
Thousand Oaks, US HQ
Hydra, DZ
Vicente López, AR
Sydney, AU
Wien, AT
Diegem, BE
Santo Amaro, BR
see more
Employees
Employees
1220% increase
Employees
563
Employees
24
Employees
14
Employees
25,200

Financial

Revenue (est.)
Revenue (est.)
N/A
Revenue (est.)
₩124.6b (FY, 2023)
Revenue (est.)
N/A
Revenue (est.)
N/A
Revenue (est.)
$36.8b (FY, 2025)
Cost of goods
Cost of goods
N/A
Cost of goods
₩104.4b (FY, 2023)
Cost of goods
N/A
Cost of goods
N/A
Cost of goods
$12b (FY, 2025)
Gross profit
Gross profit
N/A
Gross profit
₩20.5b (FY, 2023)
Gross profit
N/A
Gross profit
N/A
Gross profit
$24.7b (FY, 2025)
Net income
Net income
N/A
Net income
(₩33.6b) (FY, 2023)
Net income
N/A
Net income
N/A
Net income
$7.7b (FY, 2025)
For sources of this data, please see the company profile

View Company Profiles

Kolon Life Science
HQ
Employees
563

Kolon Life Science is a cell and gene therapy company.

View company
CytoMed Therapeutics
HQ
Singapore, SG
Employees
24

CytoMed Therapeutics is a company that focuses on translating its technologies into gamma delta (γδ) T cell- and natural killer (NK) cell-based immunotherapeutics for the treatment of cancers.

View company
Reglagene
HQ
Tucson, US
Employees
14

Reglagene is a company that discovers and develops noninvasive therapeutic solutions that regain control of genes exploited by cancer to keep patients responsive to treatment.

View company
Amgen
HQ
Thousand Oaks, US
Employees
25,200

Amgen (formerly known as Applied Molecular Genetics) is a biotechnology company that discovers, develops, manufactures, and delivers human therapeutics.

View company